Overbasalization: Addressing Hesitancy in Treatment Intensification Beyond Basal Insulin

doi:10.2337/cd19-0061

Review

. 2020 Jul;38(3):304-310.

doi: 10.2337/cd19-0061.

Overbasalization: Addressing Hesitancy in Treatment Intensification Beyond Basal Insulin

Kevin Cowart¹

Affiliations

Affiliation

¹ Department of Pharmacotherapeutics & Clinical Research, Taneja College of Pharmacy and Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL.

PMID: 32699482
PMCID: PMC7364465
DOI: 10.2337/cd19-0061

Review

Overbasalization: Addressing Hesitancy in Treatment Intensification Beyond Basal Insulin

Kevin Cowart. Clin Diabetes. 2020 Jul.

. 2020 Jul;38(3):304-310.

doi: 10.2337/cd19-0061.

Author

Kevin Cowart¹

Affiliation

¹ Department of Pharmacotherapeutics & Clinical Research, Taneja College of Pharmacy and Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL.

PMID: 32699482
PMCID: PMC7364465
DOI: 10.2337/cd19-0061

No abstract available

PubMed Disclaimer

Cited by

Quantifying and Characterizing the Presence of Insulin Overbasalization in a Family Medicine Practice.
Stewart-Lynch A, Meyers R, Sidig D, McConville SO, Heiple L. Stewart-Lynch A, et al. Clin Diabetes. 2024 Spring;42(2):266-273. doi: 10.2337/cd23-0044. Epub 2023 Nov 10. Clin Diabetes. 2024. PMID: 38694250
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2024.
American Diabetes Association Professional Practice Committee. American Diabetes Association Professional Practice Committee. Diabetes Care. 2024 Jan 1;47(Suppl 1):S158-S178. doi: 10.2337/dc24-S009. Diabetes Care. 2024. PMID: 38078590 Review.
The Hypoglycemic Fear Syndrome: Understanding and Addressing This Common Clinical Problem in Adults With Diabetes.
Polonsky WH, Guzman SJ, Fisher L. Polonsky WH, et al. Clin Diabetes. 2023 Fall;41(4):502-509. doi: 10.2337/cd22-0131. Epub 2023 May 25. Clin Diabetes. 2023. PMID: 37849521
Simplification of Complex Insulin Regimens with IdegLira in People with Type 2 Diabetes: Literature Review and Clinical Recommendations.
Builes-Montaño C, Wandurraga E, Ramírez A, Ordóñez JE. Builes-Montaño C, et al. Diabetes Ther. 2023 Nov;14(11):1959-1976. doi: 10.1007/s13300-023-01471-9. Epub 2023 Sep 22. Diabetes Ther. 2023. PMID: 37736786 Free PMC article.
Impact of Overbasalization on Clinical Outcomes in Patients With Type 2 Diabetes: A Post Hoc Analysis of a Large Randomized Controlled Trial.
Cowart K, Vascimini A, Kumar A, Tsalatsanis A, Saba Y, Carris NW. Cowart K, et al. Clin Diabetes. 2023 Spring;41(2):147-153. doi: 10.2337/cd22-0046. Epub 2023 Jul 12. Clin Diabetes. 2023. PMID: 37092152 Free PMC article.

See all "Cited by" articles

References

1. Kazemian P, Shebl FM, McCann N, Walensky RP, Wexler DJ. Evaluation of the cascade of diabetes care in the United States, 2005–2016. JAMA Intern Med 2019;179:1376–1385 - PMC - PubMed
1. Stark Casagrande S, Fradkin JE, Saydah SH, Rust KF, Cowie CC. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988–2010. Diabetes Care 2013;36:2271–2279 - PMC - PubMed
1. Mauricio D, Meneghini L, Seufert J, et al. . Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA. Diabetes Obes Metab 2017;19:1155–1164 - PMC - PubMed
1. Wu N, Aagren M, Boulanger L, Friedman M, Wilkey K. Assessing achievement and maintenance of glycemic control by patients initiating basal insulin. Curr Med Res Opin 2012;28:1647–1656 - PubMed
1. Dalal MR, Grabner M, Bonine N, Stephenson JJ, DiGenio A, Bieszk N. Are patients on basal insulin attaining glycemic targets? Characteristics and goal achievement of patients with type 2 diabetes mellitus treated with basal insulin and physician-perceived barriers to achieving glycemic targets. Diabetes Res Clin Pract 2016;121:17–26 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources

[1] Kazemian P, Shebl FM, McCann N, Walensky RP, Wexler DJ. Evaluation of the cascade of diabetes care in the United States, 2005–2016. JAMA Intern Med 2019;179:1376–1385 - PMC - PubMed

[2] Kazemian P, Shebl FM, McCann N, Walensky RP, Wexler DJ. Evaluation of the cascade of diabetes care in the United States, 2005–2016. JAMA Intern Med 2019;179:1376–1385 - PMC - PubMed

[3] Stark Casagrande S, Fradkin JE, Saydah SH, Rust KF, Cowie CC. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988–2010. Diabetes Care 2013;36:2271–2279 - PMC - PubMed

[4] Stark Casagrande S, Fradkin JE, Saydah SH, Rust KF, Cowie CC. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988–2010. Diabetes Care 2013;36:2271–2279 - PMC - PubMed

[5] Mauricio D, Meneghini L, Seufert J, et al. . Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA. Diabetes Obes Metab 2017;19:1155–1164 - PMC - PubMed

[6] Mauricio D, Meneghini L, Seufert J, et al. . Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA. Diabetes Obes Metab 2017;19:1155–1164 - PMC - PubMed

[7] Wu N, Aagren M, Boulanger L, Friedman M, Wilkey K. Assessing achievement and maintenance of glycemic control by patients initiating basal insulin. Curr Med Res Opin 2012;28:1647–1656 - PubMed

[8] Wu N, Aagren M, Boulanger L, Friedman M, Wilkey K. Assessing achievement and maintenance of glycemic control by patients initiating basal insulin. Curr Med Res Opin 2012;28:1647–1656 - PubMed

[9] Dalal MR, Grabner M, Bonine N, Stephenson JJ, DiGenio A, Bieszk N. Are patients on basal insulin attaining glycemic targets? Characteristics and goal achievement of patients with type 2 diabetes mellitus treated with basal insulin and physician-perceived barriers to achieving glycemic targets. Diabetes Res Clin Pract 2016;121:17–26 - PubMed

[10] Dalal MR, Grabner M, Bonine N, Stephenson JJ, DiGenio A, Bieszk N. Are patients on basal insulin attaining glycemic targets? Characteristics and goal achievement of patients with type 2 diabetes mellitus treated with basal insulin and physician-perceived barriers to achieving glycemic targets. Diabetes Res Clin Pract 2016;121:17–26 - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Overbasalization: Addressing Hesitancy in Treatment Intensification Beyond Basal Insulin

Affiliation

Overbasalization: Addressing Hesitancy in Treatment Intensification Beyond Basal Insulin

Author

Affiliation

Similar articles

Cited by

References

Publication types

LinkOut - more resources

Full Text Sources